MARKSANS / NSE / Biotechnology & Drugs
Marksans Pharma
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High281.4
Target Low156
Target Mean1.5
Target Median62.5
Risk Metrics
Overall RiskBalanced risk
Board Risk43.92
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Marksans Pharma (MARKSANS) Q3 25/26 earnings summary Quartr
Marksans Pharma Acquires Germany''s ABCnow GmbH Rediff MoneyWiz
Marksans Pharma to acquire German firm ABCnow GmbH for €892,384 scanx.trade
Marksans Pharma share price jumps nearly 4% on acquisition of German pharma company ABCnow Gmbh Upstox
Marksans Pharma Limited Financial Disclosures & Filings TradingView
Marksans Pharma FY26 net profit rises to ₹4,200.64 million scanx.trade
Stock FAQs
What is the symbol and ISIN of Marksans Pharma?
Marksans Pharma has the symbol MARKSANS and ISIN - INE750C01026.
What is the current price of Marksans Pharma?
Marksans Pharma is currently trading at INR 267.10.
What are the year high and year low of Marksans Pharma?
Marksans Pharma has a year high of INR 281.40 and a year low of INR 156.00.
What is the market capitalization of Marksans Pharma?
Marksans Pharma has a market capitalization of INR 12,146.56 crore.
What is the P/E ratio of Marksans Pharma?
Marksans Pharma has a P/E ratio of 17.00.
What is the dividend yield of Marksans Pharma?
Marksans Pharma has a dividend yield of 0.33%.
How is the financial performance of Marksans Pharma based on revenue, net income, and EPS?
Marksans Pharma has revenue of INR 29,509.38 crore, net income of INR 4,179.00 crore, and EPS of INR 9.23.
What is the book value of Marksans Pharma?
Marksans Pharma has a book value of INR 63.14.
What is the debt-to-equity ratio of Marksans Pharma?
Marksans Pharma has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Marksans Pharma?
Marksans Pharma has a price-to-book ratio of 4.23 and a price-to-sales ratio of 0.41.
© SharekeyX | Rusaka Technologies 2024-2026